v3.26.1
Stockholders’ Deficit
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Stockholders’ Deficit

Note 9 – Stockholders’ Deficit

 

During 2025, the Company amended its Articles of Incorporation to increase the number of authorized shares of common stock to 5,000,000,000 shares. As of March 31, 2026, there were 1,649,816,690 shares of common stock issued and outstanding.

 

Stock Issued for Services and Stock-Based Compensation

 

During the quarter ended March 31, 2026, the Company issued an aggregate of 336,894,936 shares of common stock to directors, officers, and service providers in exchange for services rendered during the quarter . The shares were valued at an aggregate fair value of $67,379 based on the OTC market closing price of $0.0002 per share on the respective grant dates.

 

During the years ended December 31, 2025 and 2024, the Company recognized stock-based compensation expense of $439,054 and $440,256, respectively, related to the vesting of common stock awards issued to the Company’s Chairman and Chief Executive Officer.

 

For additional information regarding common stock issuances during 2023, see the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.